Literature DB >> 24716861

Evaluation of ovarian reserve tests in women with systemic lupus erythematosus.

Pasa Ulug1, Gokalp Oner, Burcu Kasap, Emin Murat Akbas, Fatih Ozcicek.   

Abstract

OBJECTIVE: Impact of systemic lupus erythematosus (SLE) on fertility may be negative, and ovarian function can be also reduced by autoimmune oophoritis. In this article, we evaluated the ovarian reserve of pre-menopausal women firstly diagnosed with systemic lupus erythematosus (SLE).
METHODS: This was a prospective controlled study which included twenty women with SLE and twenty healthy women as controls in the reproductive age. Basal levels of FSH, estradiol (E2), and LH on cycle day 3 were measured. All participants underwent transvaginal ultrasonographic examination on the third day of their menstrual periods for the determination of ovarian volume (OV) and total antral follicle count (AFC).
RESULTS: A significant difference in FSH, LH, and E2 levels was observed between women with SLE and healthy controls. There was a statistically significant reduction in total AFC and OV in SLE group. Age was associated negatively with AFC, whereas positively with FSH and LH. Menstrual irregularity was significantly higher in SLE patients than control. AFC was the most reliable test to show the menstrual irregularity and negatively correlated each other in women with SLE.
CONCLUSION: In this preliminary study, the first in SLE patients, we illustrated that women with SLE had lower ovarian reserves and higher menstrual irregularity compared with healthy controls according to hormonal and ultrasonographical evaluation.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Antral follicle count; ovarian reserve; systemic lupus erythematosus

Mesh:

Substances:

Year:  2014        PMID: 24716861     DOI: 10.1111/aji.12249

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  4 in total

1.  Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.

Authors:  Nádia Filipa Esteves Martins; Maria Inês Seixas; Joaquim Polido Pereira; Maria Manuela Costa; João Eurico Fonseca
Journal:  Clin Rheumatol       Date:  2017-08-22       Impact factor: 2.980

Review 2.  Pharmacological Approach to Managing Childhood-Onset Systemic Lupus Erythematosus During Conception, Pregnancy and Breastfeeding.

Authors:  Nicole Bitencourt; Bonnie L Bermas
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

3.  Characteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study.

Authors:  Jessica H Knight; Penelope P Howards; Jessica B Spencer; Katina C Tsagaris; Sam S Lim
Journal:  Lupus Sci Med       Date:  2016-09-22

4.  Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study.

Authors:  Shefali Khanna Sharma; Siddharth Jain; Pooja Bahl; Pragna Potturi; Manish Rathi; Shankar Naidu; Naresh Sachdeva; Varun Dhir; Sanjay Jain
Journal:  Arthritis Res Ther       Date:  2020-08-14       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.